DMD and Duchenne muscular dystrophy: To test a potential endocannabinoid-based therapeutic treatment for DMD patients, and given the remarkable difficulty in isolating satellite cells from a muscle biopsy specimens28, we isolated primary myoblasts from nine different donors (ranging from 1 to 7 years old) diagnosed with DMD caused by different mutations in the dystrophin gene (Supplementary Table 2).